SENISCA

University of Exeter spinout developing senotherapeutic interventions through modulation of dysregulated RNA splicing

Leveraging the power of senolytics to eliminate senescence cells

Longevity Technology discusses senescent cells with Steve Matheson, CEO of Combilytics (YouTube)

Cellular Senescence Network (SenNet)

Consortium to comprehensively identify and characterize the differences in senescent cells across the body

Rejuveron

Company that develops and invests in drugs and technologies which prolong human lifespan.

Rubedo Life Sciences

Extending Health Span and Reverting Age-Related Diseases.

SIWA Therapeutics

Biotechnology company producing therapy that targets and destroys senescent cells.

Senolytic Therapeutics (Senolytx)

Pharmaceutical company that develops a novel class of medicines by targeting damaged cells.

Cleara Biotech

Cleara is developing therapeutics to eliminate senescent cells.

UNITY Biotechnology

Biotechnology company devoted to research of restoring human health

Dorian Therapeutics

Anti-aging company developing senoblockers.

Atropos Therapeutics

Biopharmaceutical company focused on discovering and developing drugs against aging disorders and cancer.

Oncosence

Company that target cancer by developing senescence inducing and senolytic (senescent cell killing) compounds.

Oisin Biotechnologies

Drug development company focused on the senolytic technology to fight age-related diseases

Deciduous Therapeutics

Company developing a novel class of immune-modulatory therapies designed to promote a healthy lifespan.

OS-01 BODY: Live Q&A with OneSkin’s Founders

14-Apr-2022

Learn how and why OS-01 BODY was developed and how it can help you achieve your healthiest skin yet

CULS Webinar: Marco Quarta

17-Feb-2022

Online webinar by Cambridge University Longevity Society with Marco Quarta, Co-Founder & CEO of Rubedo Life Sciences as speaker

TAmiRNA

Biotech company that specializes in the discovery and validation of microRNA biomarkers.

Velabs Therapeutics

Fast generation of functional therapeutic antibodies.

Numeric Biotech

Biotechnology company focused on development of treatments for age related diseases..

Eternans

Biotechnology company developing senolytic agents.

UK SPINE Annual Conference 2020

11-Nov-2020 to 20-Nov-2020

Series of events focussed on research and innovation in geroscience and ageing therapeutics

CellAge

working with the aim to develop synthetic promoters that would be able to specifically identify senescent cells

Biotein

Company in the field of longevity and biotechnology that aims to provide a novel way to eradicate senescent cells.